• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物反馈疗法在慢性便秘和大便失禁临床治疗中的疗效

Efficacy of Biofeedback Therapy in Clinical Practice for the Management of Chronic Constipation and Fecal Incontinence.

作者信息

Parker Colleen H, Henry Stanley, Liu Louis W C

机构信息

Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Can Assoc Gastroenterol. 2019 Aug;2(3):126-131. doi: 10.1093/jcag/gwy036. Epub 2018 Jul 14.

DOI:10.1093/jcag/gwy036
PMID:31294375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6619409/
Abstract

BACKGROUND

Chronic constipation (CC) and fecal incontinence (FI) are often secondary to pelvic floor neuromuscular sensory or motor dysfunction. Biofeedback therapy (BFT) uses visual and verbal feedback to improve anorectal coordination, strength and sensation. In clinical trials, BFT demonstrated response rates between 70% and 80%. The purpose of this study is to determine the effectiveness of BFT in clinical practice.

METHODS

In this retrospective observational cohort study, the charts of all patients who completed BFT at our centre were reviewed. A positive response to BFT was defined as improvement in ARM profile from baseline or subjective symptom improvement or both. Descriptive statistics were used to analyze the data.

RESULTS

One hundred thirty patients with an average age of 57.5 ± 16.4 years and 79.2% female were included. Of all patients, 43.1% were referred for CC, 37.7% for FI, 16.9% for alternating CC and FI, and 2.3% for rectal pain. The overall response rate to BFT was 76.2% (n=99). Of those that responded, 64.6% (n=64) demonstrated both ARM and symptom improvement, 27.3% (n=27) had ARM improvement but no symptom improvement, and 8.1% (n=8) had symptom improvement but no ARM improvement. In patients with FI, the overall response rate was 79.6% (n=39) with symptom improvement in 67.3% (n=33). In those with CC with dyssynergic defecation (n=53), the overall response rate was 69.8% (n=37); however, only 45.3% (n=24) had symptomatic improvement.

CONCLUSION

In our clinical practice, although overall response rates to BFT are similar to published reports, patients with CC with dyssynergic defecation are less likely to have symptomatic response compared with those with FI.

摘要

背景

慢性便秘(CC)和大便失禁(FI)通常继发于盆底神经肌肉感觉或运动功能障碍。生物反馈疗法(BFT)利用视觉和言语反馈来改善肛门直肠协调性、力量和感觉。在临床试验中,BFT的有效率在70%至80%之间。本研究的目的是确定BFT在临床实践中的有效性。

方法

在这项回顾性观察性队列研究中,对在我们中心完成BFT的所有患者的病历进行了回顾。对BFT的阳性反应定义为与基线相比肛门直肠轮廓改善或主观症状改善或两者皆有。使用描述性统计分析数据。

结果

纳入了130例患者,平均年龄为57.5±16.4岁,女性占79.2%。在所有患者中,43.1%因CC就诊,37.7%因FI就诊,16.9%因CC和FI交替出现就诊,2.3%因直肠疼痛就诊。对BFT的总体有效率为76.2%(n=99)。在有反应的患者中,64.6%(n=64)表现出肛门直肠和症状均改善,27.3%(n=27)有肛门直肠改善但无症状改善,8.1%(n=8)有症状改善但无肛门直肠改善。在FI患者中,总体有效率为79.6%(n=39),67.3%(n=33)有症状改善。在患有排便协同失调的CC患者(n=53)中,总体有效率为69.8%(n=37);然而,只有45.3%(n=24)有症状改善。

结论

在我们的临床实践中,尽管对BFT的总体有效率与已发表的报告相似,但与FI患者相比,患有排便协同失调的CC患者出现症状性反应的可能性较小。

相似文献

1
Efficacy of Biofeedback Therapy in Clinical Practice for the Management of Chronic Constipation and Fecal Incontinence.生物反馈疗法在慢性便秘和大便失禁临床治疗中的疗效
J Can Assoc Gastroenterol. 2019 Aug;2(3):126-131. doi: 10.1093/jcag/gwy036. Epub 2018 Jul 14.
2
Efficacy of combination of biofeedback therapy and pelvic floor muscle training in dyssynergic defecation.生物反馈疗法联合盆底肌训练治疗协同性排便障碍的疗效。
Acta Gastroenterol Belg. 2021 Oct-Dec;84(4):577-583. doi: 10.51821/84.4.008.
3
Biofeedback therapy for anorectal functional disorder: Malaysian colorectal tertiary centre experience.用于肛门直肠功能障碍的生物反馈疗法:马来西亚结直肠三级中心的经验
Ann Med Surg (Lond). 2022 May 25;79:103848. doi: 10.1016/j.amsu.2022.103848. eCollection 2022 Jul.
4
Biofeedback therapy for defecatory dysfunction: "real life" experience.生物反馈疗法治疗排便功能障碍:“真实生活”中的经验。
J Clin Gastroenterol. 2013 Mar;47(3):252-5. doi: 10.1097/MCG.0b013e318266f43a.
5
The Efficacy of Biofeedback Therapy in Patients with Solitary Rectal Ulcer and Dyssynergic Defecation.生物反馈疗法对孤立性直肠溃疡和协同性排便障碍患者的疗效。
Dig Dis. 2022;40(6):728-733. doi: 10.1159/000522180. Epub 2022 Jan 31.
6
Integrated low-intensity biofeedback therapy in fecal incontinence: evidence that "good" in-home anal sphincter exercise practice makes perfect.综合低强度生物反馈疗法治疗大便失禁:证据表明“良好的”家庭肛门括约肌锻炼实践成就完美效果。
Neurogastroenterol Motil. 2017 Jan;29(1). doi: 10.1111/nmo.12912. Epub 2016 Jul 20.
7
Technique of functional and motility test: how to perform biofeedback for constipation and fecal incontinence.技术的功能和运动试验:如何执行生物反馈治疗便秘和大便失禁。
J Neurogastroenterol Motil. 2013 Oct;19(4):532-7. doi: 10.5056/jnm.2013.19.4.532. Epub 2013 Oct 7.
8
The Efficacy of Biofeedback Treatment in Patients with Fecal Incontinence.生物反馈治疗对粪便失禁患者的疗效。
Turk J Gastroenterol. 2021 Jul;32(7):567-574. doi: 10.5152/tjg.2021.20430.
9
A Practical Guide to Biofeedback Therapy for Pelvic Floor Disorders.盆底功能障碍生物反馈疗法实用指南。
Curr Gastroenterol Rep. 2019 Apr 23;21(5):21. doi: 10.1007/s11894-019-0688-3.
10
Abdominal Symptoms Are Common and Benefit from Biofeedback Therapy in Patients with Dyssynergic Defecation.腹部症状在排便协同失调患者中很常见,且生物反馈疗法对其有益。
Clin Transl Gastroenterol. 2015 Jul 30;6(7):e105. doi: 10.1038/ctg.2015.30.

引用本文的文献

1
Investigating the effects of using Tecar therapy with biofeedback compared to biofeedback alone in the treatment of fecal incontinence in children aged 4 to 16 years: a randomized clinical trial study.研究与单独使用生物反馈相比,使用伴有生物反馈的透热疗法治疗4至16岁儿童大便失禁的效果:一项随机临床试验研究。
Gastroenterol Hepatol Bed Bench. 2025;18(1):82-90. doi: 10.22037/ghfbb.v18i1.3093.
2
Optimizing the Utility of Anorectal Manometry for Diagnosis and Therapy: A Roundtable Review and Recommendations.优化肛肠测压在诊断和治疗中的效用:圆桌会议综述及建议。
Clin Gastroenterol Hepatol. 2023 Oct;21(11):2727-2739.e1. doi: 10.1016/j.cgh.2023.05.025. Epub 2023 Jun 9.
3
Dyssynergic Defecation: A Comprehensive Review on Diagnosis and Management.协同失调性排便:诊断与管理的全面综述。
Turk J Gastroenterol. 2023 Mar;34(3):182-195. doi: 10.5152/tjg.2023.22148.
4
Clinical Characteristics of Adult Functional Constipation Patients with Rectoanal Areflexia and Their Response to Biofeedback Therapy.伴有直肠肛门反射消失的成年功能性便秘患者的临床特征及其对生物反馈治疗的反应
Diagnostics (Basel). 2023 Jan 10;13(2):255. doi: 10.3390/diagnostics13020255.
5
The effect of biofeedback interventions on pain, overall symptoms, quality of life and physiological parameters in patients with pelvic pain : A systematic review.生物反馈干预对盆腔疼痛患者疼痛、总体症状、生活质量和生理参数的影响:系统评价。
Wien Klin Wochenschr. 2022 Jan;134(Suppl 1):11-48. doi: 10.1007/s00508-021-01827-w. Epub 2021 Mar 22.
6
Biofeedback for Pelvic Floor Disorders.盆底功能障碍的生物反馈疗法
Clin Colon Rectal Surg. 2021 Jan;34(1):56-61. doi: 10.1055/s-0040-1714287. Epub 2020 Sep 4.
7
Physiotherapy for Prevention and Treatment of Fecal Incontinence in Women-Systematic Review of Methods.女性大便失禁的预防和治疗物理疗法——方法的系统评价
J Clin Med. 2020 Oct 12;9(10):3255. doi: 10.3390/jcm9103255.
8
The Effectiveness of Acupuncture in Management of Functional Constipation: A Systematic Review and Meta-Analysis.针刺治疗功能性便秘的有效性:一项系统评价与Meta分析
Evid Based Complement Alternat Med. 2020 Jun 17;2020:6137450. doi: 10.1155/2020/6137450. eCollection 2020.

本文引用的文献

1
The Use of Standardized Questions in Identifying Patients with Dyssynergic Defecation.使用标准化问题识别排便协同失调患者
J Can Assoc Gastroenterol. 2018 Mar 30;1(2):60-66. doi: 10.1093/jcag/gwy010. eCollection 2018 Jun.
2
Prevalence of and Factors Associated With Fecal Incontinence: Results From a Population-Based Survey.基于人群的调查:粪便失禁的流行情况及相关因素。
Gastroenterology. 2018 May;154(6):1672-1681.e3. doi: 10.1053/j.gastro.2018.01.062. Epub 2018 Feb 3.
3
Chronic constipation.慢性便秘。
Nat Rev Dis Primers. 2017 Dec 14;3:17095. doi: 10.1038/nrdp.2017.95.
4
Diagnosis and Treatment of Dyssynergic Defecation.排便协同失调的诊断与治疗
J Neurogastroenterol Motil. 2016 Jul 30;22(3):423-35. doi: 10.5056/jnm16060.
5
Functional Anorectal Disorders.功能性肛门直肠疾病
Gastroenterology. 2016 Mar 25. doi: 10.1053/j.gastro.2016.02.009.
6
The American Society of Colon and Rectal Surgeons' Clinical Practice Guideline for the Treatment of Fecal Incontinence.美国结肠和直肠外科医师协会《大便失禁治疗临床实践指南》
Dis Colon Rectum. 2015 Jul;58(7):623-36. doi: 10.1097/DCR.0000000000000397.
7
ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders.ANMS-ESNM关于肛门直肠疾病生物反馈治疗的立场文件和共识指南。
Neurogastroenterol Motil. 2015 May;27(5):594-609. doi: 10.1111/nmo.12520. Epub 2015 Apr 1.
8
The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden.以便秘为主的肠易激综合征和慢性特发性便秘的范围:美国评估症状、就医情况和疾病负担的调查
Am J Gastroenterol. 2015 Apr;110(4):580-7. doi: 10.1038/ajg.2015.67. Epub 2015 Mar 17.
9
Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis.社区中慢性特发性便秘的患病率及相关危险因素:系统评价和荟萃分析。
Am J Gastroenterol. 2011 Sep;106(9):1582-91; quiz 1581, 1592. doi: 10.1038/ajg.2011.164. Epub 2011 May 24.
10
Systematic review: impact of constipation on quality of life in adults and children.系统评价:便秘对成人和儿童生活质量的影响。
Aliment Pharmacol Ther. 2010 May;31(9):938-49. doi: 10.1111/j.1365-2036.2010.04273.x. Epub 2010 Feb 20.